Arab Press

بالشعب و للشعب
Friday, Jun 20, 2025

Emergency vaccines ‘have proved effectiveness’, Chinese drug firm says

Emergency vaccines ‘have proved effectiveness’, Chinese drug firm says

An official from China National Biotec Group says the evidence from an emergency use scheme suggests the products are working.

Hundreds of thousands of Chinese have been given two experimental Covid-19 vaccines under an emergency scheme without a single case of infection, a top official with a state-owned vaccine developer has said.

Zhou Song, secretary for the commission for discipline inspection with China National Biotec Group, also said the company’s two candidate vaccines were likely to protect people for up to three years.

Zhou told China National Radio on Monday that the firm’s vaccines were the most widely used in the emergency scheme, adding: “Hundreds of thousands have taken the shot and no one has shown any obvious adverse effects or got infected.”

CNBG’s two vaccines are still undergoing phase three trials for safety and efficacy in several countries, including the United Arab Emirates, Bahrain, Peru, Morocco, Argentina and Jordan.

China’s emergency vaccine scheme began in late July and allows high-risk groups – including health care workers, diplomats and people who work abroad – to receive vaccines that have not yet been approved by regulators.


Zhou said that this group included tens of thousands of people who work overseas adding that the lack of infections “proves the effectiveness of the vaccines”.

Eight vaccines are currently undergoing phase three trials around the world, including four made by Chinese companies.

Three of the Chinese vaccines – including the two made by CNBG and one developed by Beijing based Sinovac-have been approved for emergency civilian use, while a fourth has been given the greenlight for use by the military.

Sinovac’s product is currently being tested in Brazil and Indonesia and the trial is expected to expand to more countries. The company has reportedly said that tens of thousands of people have already been given the vaccine under China’s emergency use scheme.

Meanwhile, the Chinese military has given the green light to the limited use of a candidate vaccine developed by CanSino and the Academy of Military Medical Sciences.

Yu Xuefeng, chairman of Tianjin-based CanSino Biologics, told state broadcaster China Central Television that those who needed the vaccine included troops “on peacekeeping missions in countries and regions where Covid-19 has yet to be put under control”. He did not say how many people had been given the vaccine.

CNBG’s vaccines have also been offered to employees of some businesses. Last week the pharmaceutical company announced that it had signed a deal with telecoms giant Huawei to offer vaccines and other treatments to employees.

The news website Caixin has also reported that an unnamed state-owned company in Beijing has also been offering its staff a vaccine since June, a month before the emergency use scheme started.


Two of CNBG’s vaccines have been approved for emergency use.


The report also said that the company – which operates in more than 30 countries – had asked all employees who have to travel overseas to take the injections and quoted one employee as saying that hundreds of people had agreed to do so.

Caixin also reported the Civil Aviation Administration of China has urged airline workers to take one of the candidate vaccines.

On Monday, Zhou dismissed suggestions that the vaccines might only offer protection for short periods.

The Covid-19 candidates were first tested on 180 senior executives and officials of CNBG’s parent company, the China National Pharmaceutical Group, also known as Sinopharm.

Zhou said they still showed high levels of antibodies, and added: “At present, based on the results of animal experiments, phased research results, and similar vaccines using similar technology, it is without question that immunity can last from one to three years.”

He also said it looks unnecessary to take annual shots like flu shots and the vaccine has covered the current known mutations of the coronavirus that causes Covid-19.

“There are indeed several subtypes of the virus that are mutating, but its main gene sequence and protein level has not fundamentally changed. The inactivated vaccine will have no problem in dealing with these mutated viruses in the next few years and can cover them,” Zhou said.

CNBG has built two secure facilities in Beijing and Wuhan to produce the vaccines. He said the annual production capacity of more than 220 million doses will rise to between 800 million to one billion when work to extend the facilities is complete.

Newsletter

Related Articles

Arab Press
0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Syria to Reconnect to Global Economy After 14 Years of Isolation
Saudi Arabia Faces Uncertainty Over Succession After Mohammed bin Salman
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Majority of French Voters View Macron's Presidency as a Failure
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
Iran Warns Europe Against Politicizing UN Nuclear Report
Businessman Mauled by Lion at Luxury Namibian Lodge
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
European and Arab Ministers Convene in Madrid to Address Gaza Conflict
Head of Gaza Aid Group Resigns Amid Humanitarian Concerns
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
×